Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung...

by Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Dinesh Khanna
Published 2020-06-01

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

by Dinesh Khanna, Philip J. Clements, Elizabeth R. Volkmann, Holly Wilhalme, Chi-hong Tseng, Daniel E. Furst, Michael D. Roth, Oliver Distler, Donald P. Tashkin
Published 2019-01-01

Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema.

by Jeanine M D'Armiento, Monica P Goldklang, Andrew A Hardigan, Patrick Geraghty, Michael D Roth, John E Connett, Robert A Wise, Frank C Sciurba, Steven M Scharf, Jincy Thankachen, Monirul Islam, Andrew J Ghio, Robert F Foronjy
Published 2013-01-01